Your institution may have access to this item. Find your institution then sign in to continue.
Title
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.
Authors
Lori F; De Forni D; Katabira E; Baev D; Maserati R; Calarota SA; Cahn P; Testori M; Rakhmanova A; Stevens MR